NCT06839794 Effect of Cognitively Challenging Physical Activity on Executive Functions in Pediatric Cancer Patients
| NCT ID | NCT06839794 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bern |
| Condition | Childhood Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-05-10 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2025-05-10 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
When it comes to exercise and sport for children and adolescents with cancer, there is often still the opinion that physical activity has a negative effect on the weakened body suffering from cancer. Many studies show that the opposite is the case: physical activity for children and adolescents with cancer do not jeopardise the success of treatment, but rather promote it. It has been shown that physical activity has a positive effect on motor skills, physical fitness, sleep quality, fatigue symptoms, body image and general quality of life in children and adolescents with cancer. In addition, physical activity leads to an improved fat-to-muscle ratio, metabolic status, bone strength and reduces cardiovascular disease. Furthermore, various studies show that oncological patients with sarcopenia (loss of muscle mass) and frailty have a poorer response to their cancer therapy. This broad spectrum of effects of physical activity leads to improved and faster rehabilitation, is directly linked to the success of treatment and has led to exercise being an integral part of treatment in many paediatric oncology centres worldwide. Furthermore, more exercise that includes playful cognitive tasks is expected to lead to improved attention, memory and academic achievement. Besides, it is important to try to get children to exercise at home outside of the inpatient setting. Hybrid (on-site and digital meetings) programmes also work for children and adolescents. Additionally, the research project offers sports counselling after the end of therapy to reintegrate the patients into everyday sporting life, be it in a club or at school. The central question of the research project is: Does cognitive challenging physical activity developed for children and adolescents undergoing acute cancer therapy improve cognitive and motor performance compared to a control group receiving standard care?
Eligibility Criteria
Inclusion Criteria: * Written informed consent of parents / legal guardian and participants, where applicable * Diagnosis of any type of cancer requiring chemo- and/or radiotherapy, or CNS surgery, expected to last a minimum of at least 6 weeks at the time of recruitment * Age: 6-17.99 years at time of recruitment Exclusion Criteria: * Cognitive and physical disabilities that prevent participation in the intervention. * Inability to follow the procedures of the study, e.g. due to language problems. * Enrolment of the investigator, his/her family members, employees and other dependent persons. * Denied written informed consent from participants.
Contact & Investigator
Valentin Benzing, Dr.
STUDY CHAIR
University Bern
Frequently Asked Questions
Who can join the NCT06839794 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Childhood Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06839794 currently recruiting?
Yes, NCT06839794 is actively recruiting participants. Contact the research team at valentin.benzing@unibe.ch for enrollment information.
Where is the NCT06839794 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT06839794 clinical trial?
NCT06839794 is sponsored by University of Bern. The principal investigator is Valentin Benzing, Dr. at University Bern. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.